Results 111 to 120 of about 8,552 (153)

Diagnostic and prognostic value of fibroblast growth factor 23 in acute kidney injury: systematic review and meta-analysis. [PDF]

Ren Fail
Pei X, Gao H, Zhang L.
europepmc   +1 more source

Impact of burosumab on kinetics of intact FGF23 values after the removal of a causative tumor in a patient with tumor-induced osteomalacia. [PDF]

JBMR Plus
Irie K, Sasaki K, Furukawa K, Jiajue R, Adachi N, Kimura S, Hoshino Y, Hidaka N, Kato H, Takeuchi M, Tanaka S, Nangaku M, Saito T, Makita N, Ito N.   +14 more
europepmc   +1 more source

Phosphaturic Mesenchymal Tumor: From Invisibility to Bedridden Morbidity. [PDF]

J ASEAN Fed Endocr Soc
Mukherjee R, Pattashanee SK, Singh BK, Krishna A, Soren S, Damle AN, Sharma MC, Seenu V.   +7 more
europepmc   +1 more source

High-salt diet modulates endocrine regulation between cortisol and FGF23. [PDF]

Pflugers Arch
Moor MB, Sagmeister MS, Crastin A, Kopper K, Pechère-Bertschi A, Hardy RS, Feraille E, Fuster DG, Loffing J, Pathare G.   +9 more
europepmc   +1 more source

Elevated circulating fibroblast growth factor 23 is associated with acute kidney injury and mortality in coronavirus disease 2019 (COVID-19). [PDF]

J Bras Nefrol
Narayanan G, Campos MO, Groninger N, Burney HN, Hays M, Dollins M, Arroyo E, Halim A, Li Y, Sher SJ, Moe S, Lim K.   +11 more
europepmc   +1 more source

Role of fibroblast growth factor 23 in predicting CKD progression and prognosis: a systematic review and meta-analysis. [PDF]

PeerJ
Hsu JW, Wang HP, Chiang TI.
europepmc   +1 more source

Recent research progress on the etiology and pathogenesis of tumor-induced osteomalacia: A review. [PDF]

J Bone Oncol
Liu S, Xing J, Song A, Liu Y, Xia W.
europepmc   +1 more source

Severe Hypocalcemia and Hypophosphatemia Following Ferric Carboxymaltose in a Patient With Roux-en-Y Gastric Bypass. [PDF]

Cureus
Elhassan A, Ali I.
europepmc   +1 more source

Endocrine crosstalk in cardiovascular-kidney-metabolic syndrome-related heart failure: the fibroblast growth factor 23-Klotho axis and cardiometabolic therapy. [PDF]

Front Endocrinol (Lausanne)
Sun D, Wang X, Wang H, Shen Z, Meng X, Zhou Y.   +5 more
europepmc   +1 more source

Autosomal dominant hypophosphatemic rickets caused by a novel pathogenic variant in <i>FGF23</i>. [PDF]

JCEM Case Rep
Francis B, Ashok V, Ashraf A, Sasidharan Pillai S.   +3 more
europepmc   +1 more source